Infarct size has been estimated from serial serum creatine phosphokinase (CPK) changes, but the contribution of noncardiac CPK may interfere. Results would also be influenced if CPK disappearance varied with hemodynamic changes. Since MB CPK is a marker more specific to myocardium, infarct size was estimated from serum MB changes in 16 patients. In addition, 21 been measured in recent years to evaluate infarct size and therapeutic interventions.1 Prognosis,5 changes in ventricular performance,6 and altered compliance,7 early after infarction, appear to be related to infarct size assessed in this fashion. However, the initial model used1 for analysis of CPK changes requires refinement. We have recently delineated some factors limiting its use, particularly in patients with myocardial infarction complicated by hemodynamic impairment or associated with release of noncardiac CPK into the circulation.8
CHANGES IN SERUM CPK ACTIVITY have
been measured in recent years to evaluate infarct size and therapeutic interventions.1 Prognosis,5 changes in ventricular performance,6 and altered compliance,7 early after infarction, appear to be related to infarct size assessed in this fashion. However, the initial model used1 for analysis of CPK changes requires refinement. We have recently delineated some factors limiting its use, particularly in patients with myocardial infarction complicated by hemodynamic impairment or associated with release of noncardiac CPK into the circulation. 8 Our initial approach to estimation of infarct size from serum enzymes1 was based on the assumption that after myocardial infarction the rate of change of CPK activity in blood depended upon the rate of release of enzyme from the heart and the rate of its disappearance from the circulation. Cumulated CPK released from the heart was calculated from observed reported quantitative, although laborious procedure."`The new method utilizes separation of individual CPK isoenzymes in serum samples and tissue extracts by batch adsorption with glycophase DEAE glass beads (kindly provided by Corning Glassware, Medfield, Mass.). As a first step in developing this assay procedure, we purified human CPK isoenzymes to serve as standards and for use in constituting test samples of known isoenzyme composition.
Preparation of MM and MB Isoenzymes from Human Myocardium CPK isoenzymes were extracted from human myocardium obtained at necropsy; separated; and partially purified as follows: Approximately 100 grams of myocardium was ground in a chilled meat grinder, homogenized in two volumes of 10 mM KC1, 1 mM mercaptoethanol in a Waring blender, and centrifuged for 15 minutes at 600 x g. The supernatant fraction was filtered through cheese cloth and precipitated with 0.1 M NH4Cl after pH was adjusted to 9.0 with 5 M NH1OH. After precipitation and centrifugation, ethanol was added to the supernatant fraction in a final concentration of 40%. The precipitate was discarded and the supernatant dialyzed against 50 mM Tris-HCI, pH 7.4, with 1 mM mercaptoethanol with the use of a Biofiber 80 beaker at a flow rate of 100 ml/min for 30 minutes. This fraction contained both the MM and MB CPK isoenzymes. MM and MB were separated by repetitive batch adsorption with DEAE-Sephadex A-5012 equilibrated with 50 mM NaCI, 50 mM Tris-HCI, pH 7.4, and 1 mM mercaptoethanol. One ml of gel/4.8 mg protein was used. Under these conditions, MM remains in the filtrate, and MB is adsorbed to the gel. After extensive washing of the gel with the same buffer, the MB isoenzyme bound was desorbed with buffer containing 300 mM NaCI, recovered by filtration, and dialyzed against a low salt medium to avoid inactivation of CPK activity by prolonged exposure to high concentrations of salt. The concentrated dialysate, containing the MB isoenzyme free from MM, was lyophylized and stored at -200C.
Assay of CPK Isoenzyme Activity in Serum Samples CPK activity was assayed fluorometrically with the Rosalki procedure.'3 Individual CPK isoenzymes in serum samples were separated with a new micro-batch procedure utilizing glycophase DEAE glass beads. The glass beads adsorb MB CPK under selected conditions of low ionic strength, whereas MM remains free because its charge is less negative.'4MB can be desorbed by increasing the ionic strength of the medium. The glass beads are handled particularly easily because they sediment spontaneously, can be stored dry, and can be used immediately in contrast to many other chromatographic media. For our purposes, 50 ml polyearbonate centrifuge tubes containing 300 mg dry glycophase DEAE glass beads, mesh size 120-200, were preweighed. One ml of buffer containing 100 mM Tris-HCl, pH 8.0, and 3 mM dithiothreitol followed by 0.125 ml of the sample to be analyzed were added to the tube. MB CPK was adsorbed completely by equilibration for 3 min. After sedimentation of the beads, the supernatant fraction containing MM CPK was recovered quantitatively. The beads were washed twice with 45 ml of buffer.
MB CPK was desorbed from the beads by adding 100,ul of 3.8 M NaCl per gram of residual aqueous phase in the preweighed tube and agitating the mixture for 2 min. The high ionic strength supernatant fraction contained desorbed MB CPK. Under conditions used, when serum samples were constituted with human MB and MM CPK (isolated from myocardium) in a ratio of 1:10, over a range of 50 to 741 mI. U. /ml total activity, the recovery of MB activity averaged 97% (N = 15).
The reproducibility of the assay was examined in samples from patients with acute myocardial infarction as follows: each sample was assayed five times. A total of nine different samples (with average MB activity = 5, 19, 37, 49, 52, 54, 78, 96, 103 mI.U./ml) were evaluated. In each case, the standard deviation of the five determinations was 4% or less of the mean MB activity in that particular sample. Determination After each experiment postmortem examinations were performed to verify the location and integrity of cuffs and probes and the occurrence of ischemic injury in organs distal to occlusive cuffs.
Canine myocardial CPK was isolated as previously described' and radioactively labeled with 14C-formaldehyde and sodium borohydride as described by Rice When serum samples were constituted with purified human MM and MB CPK isoenzymes to produce known combinations of activity of each, the results shown in figure 1 were obtained. The relationship between MB CPK activity added to the sample and observed activity detected with the micro-batch assay system was close over a wide range of MB CPK activity. In the experiments shown, MB CPK represented from 10 to 80% of total CPK activity, over a wide range of total activity in the sample.
As shown in figure 2 the amount of MB CPK estimated by the micro-batch assay procedure in samples from patients with acute myocardial infarction correlated closely with MB activity measured with the electrophoretic-kinetic technique,1`previously demonstrated to be accurate although laborious. Thus, the assay developed in this study permitted rapid, quantitative assessment of MB CPK activity over a range from < 5 to 1000 mI.U./ml. MB Serial changes in serum MB and total CPK activity after acute myocardial infarction are shown in figure  3 . All values have been corrected by a "background" subtraction of 2 mI. U. /ml, based on activity in samples from normal subjects averaging 2 i 1 (SD) ml. U. /ml.`In general, increases in MB CPK activity corresponded to increases in total activity in the same patient, but MB CPK activity declined more rapidly. Peak serum MB CPK activity usually approximated 8 to 14% of peak total CPK, a ratio similar to that seen in myocardium. This suggests that CPK released probably came from the heart and that inhibitors of MB activity were probably not present in the serum. Occasionally MB CPK activity peaked slightly earlier than total CPK, perhaps because of its higher disappearance rate.
We have previously shown that intramuscular injections18 elevate serum CPK by releasing MM CPK from muscle. In a patient with acute myocardial infarction exposed to eight intramuscular injections Results of quantitative assay of CPK isoenzymes by glass bead adsorption. Serum samples were constituted with partially purified human MM and MB isoenzymes prepared from heart muscle. The amounts of MB CPK in each sample are shown on the abscissa. Total CPK in these samples was varied such that the proportion of MB rangedfrom 10 to 80%. As can be seen, results with the adsorption assay corresponded closely to actual amounts of MB CPK added to each sample. Serial changes in serum MB CPK and total CPK activity in a patient with acute myocardial infarction. tMVB and BB can be readily differentiated by stepwise high ionic strength elution from the glass beads after MM has been assayed in the low ionic strength eluate. However, electrophoresis combined with a previously reported kinetic-fluorometric assay" revealed no BB in any extract surveyed containing MB. Thus, MM was determined as activity in the low ionic strength eluate and all activity in the subsequently obtained high ionic strength eluate was considered to be MB.
tThe following skeletal muscles were analyzed: deltoid, pectoralis major, rectus abdominis, vastus medialis.
gastrocnemius, soleus, sternocleidomastoid. §An average value of 13l.' of MB/total CPK activity (N = 3 myocardial extracts) was obtained with the kinetic fluorometric procedure."
for 24 hours, and used to estimate infarct size. Twenty-four hours after coronary occlusion, each animal was killed and residual myocardial CPK and MB CPK activity was measured in the homogenate of the whole left ventricle. Expected myocardial MB and total CPK (i.e., that estimated to be present in the entire left ventricle prior to coronary occlusion) was calculated by multiplying the average activity in each of four 1 gram samples from nonischemic left ventricle (posterior wall) by the total left ventricular weight.' Myocardial MB and total CPK depletion were calculated by subtracting residual activity in the whole homogenate of the left ventricle from expected activity. MB and total CPK released into blood were estimated from serial changes of each in serum, using the same value for estimated distribution volume (i.e., plasma volume calculated as 5% of body weight) and a fractional disappearance rate obtained from the descending portions (as described below) of the serial serum MB and total CPK curves6 respectively. MB CPK and total CPK released were compared to myocardial MB CPK and total CPK depleted based on measured amounts of residual activity of each in the left ventricular homogenates 24 hours after coronary occlusion.
As can be seen in table 3, despite the differences in the rate of disappearance of MB and total CPK from the canine circulation (both substantially higher than corresponding values in patients), the ratio of MB CPK released to MB CPK depleted was similar to that of total CPK released to total CPK depleted in each of these five experiments. This suggests that the propor- serial MB CPK changes should be useful when total CPK is altered under these conditions.
Effects of Interventions on CPK Disappearance in Conscious Dogs
In five control experiments in which radioactively labeled CPK was injected intravenously and no perturbations were induced, enzyme activity and radioactivity declined in generally parallel fashion ( fig. 6 ). This suggests that loss of activity is associated with removal of enzyme molecules from the circulation rather than denaturation. Values for the distribution volume of CPK calculated in these five experiments by the dilution principle approximated plasma volume (range = 4.5 to 5.5% of body weight). The absolute value of kd in these experiments varied from -0.004 to -0.007, in keeping with our previous observations of wide variation in this parameter from animal to animal. Hemodynamic perturbations were implemented in 21 dogs as summarized in table 1. In each experiment kd was determined during four hour intervals before and after implementation of the intervention. The ratio of kd before and after each intervention in the same animal changed by an average of < 10%. An example of the changes in CPK activity during reduction of cardiac output by 67% is shown in figure 7 . As can be seen, despite the marked hemodynamic perturbation in this experiment, kd was not markedly affected, although two of the four animals with reduced cardiac output lost consciousness transiently, presumably because of systemic arterial hypotension. Similar results were obtained in all experiments in which cardiac output was reduced (N = 4), heart rate was accelerated to 160 to 180 beats/min by ventricular pacing, or administration of isoproterenol (N = 8), or hepatic blood flow was reduced by occlusion of the hepatic or celiac artery (N = 5). In each case, kd changed by an average of less than 10%.
Interference with renal blood flow initially appeared to decrease the rate of disappearance of CPK by a maximum of 35%. However, occlusion of the renal artery by itself liberated CPK into the circulation, and when this was subtracted from the disappearance curve observed after intravenous injection of exogenous enzyme, the calculated kd did not change markedly after renal artery occlusion. As shown in figure 5 , canine kidney contains approximately 9 I.U./g of CPK, an amount sufficient to TIME (min) Figure 7 The effects of decreased cardiac output on the disappearance rate of CPK activity (kd). Canine CPK was injected intravenously in a conscious dog previously instrumented with an occlusive cuff around the inferior vena cava (IVC) in an infra-hepatic (IH) location. Serial serum samples were assayed for CPK activity. During the interval indicated by the horizontal bar, the cuff was occluded, resulting in a 67% decrease in cardiac output, monitored with an aortic flow meter. As can be seen, the disappearance of CPK activityfrom the circulation proceeded at the same rate despite the nmrked reduction in cardiac output. The results of determination of CPK disappearance in an experiment in a conscious dog. Canine CPK was extracted and partially purified, radioactively labeled with "4C-formaldehyde, and injected intravenously in a conscious dog. Serial samples were assayed for CPK activity, radioactivity in serum, and radioactivity in protein precipitable material (precipitated with trichloroacetic acid [TCA]). As can be seen, enzyme activity (filled circles), serum radioactivity (unfilled circles), and acid precipitable activity (triangles) declined in parallel and conformed in general to a monoexponential decay. This indicates that disappearance of enzyme activity is associated with remowval of intact protein molecules from the circulation. cpm = counts/min. Changes in the rate of disappearance of serum CPK activity in a conscious dog with diminished hepatic bloodflow. Durng the interval indicated by the bar, a cuff around the celiac artery was constricted to reduce flow by 70%. As can be seen, the apparent disappearance of CPK activity declined temporarily, due to release of enzyme from viscera as demonstrated in independent experiments. However, after approximately 120 minutes, CPK disappearance again proceeded at a rate similar to that under control conditions. These results indicate that despite persistent diminution of hepatic flow, disappearance of CPK from the circulation was unimpaired after the masking effects of enzyme released from viscera had diminished.
increase serum CPK as much as 100 mI.U./ml (N = 2).
Interference with hepatic blood flow led to a transient decrease in the decline of CPK activity, probably reflecting superimposition of CPK released from the injured liver which contains a low concentration of en- Figure 9 The effects of inhibition of the reticuloendothelial system with zymosan on the disappearance rate of CPK activity. CPK was injected intravenously in a conscious animal, and zymosan was administered during the interval indicated by the horizontal bar. This intervention which blocks reticuloendothelial system activity resulted in a marked and persistent decline in the rate of disappearance of CPK activity from the circulation.
Circulation, Volume 52, November 1975 zyme, perhaps in arterial smooth muscle ( fig. 5) . Subsequently, the disappearance rate of CPK activity increased and approximated the disappearance rate before the intervention despite persistence of impaired hepatic flow ( fig. 8 ) and without reinjection of exogenous enzyme.
These results indicate that hemodynamic perturbations profoundly affecting cardiac output, heart rate, renal flow, or hepatic flow in conscious dogs did not markedly affect kd. On the other hand as shown in table 1, sodium thiamylal markedly reduced kd, in keeping with our previous observations of the effect of anesthesia.1 The lack of marked influence of profound hemodynamic alterations on kd was initially surprising to us. It suggested that disappearance of enzyme activity was due to mechanisms with substantial reserve capacity in the face of hemodynamic compromise. Observations of others studying transaminase and lactic dehydrogenase21 led us to examine the effects of the reticuloendothelial system on kd after intravenous injection of extracted dog heart CPK. When the reticuloendothelial system was blocked with zymosan,17 the CPK disappearance rate decreased substantially ( fig. 9 ).
Discussion
This study was designed to improve estimation of infarct size by measuring enzyme levels and to assess some parameters involved. Its main findings include the following: The results reported in this study were gathered in order to improve estimates of infarct size. The studies performed were not addressed specifically to predictions of infarct size based on early serum enzyme changes. Nevertheless, some considerations regarding prediction may merit discussion. In predicting infarct size from early enzyme changes, empirical algorithms have been employed which are far from ideal.8 Although comparison between observed infarct size and infarct size predicted with empirical model has been useful in analyzing small groups of patients, the closeness of fit of curves obtained with available models to observed data is not optimal. New empirical models or the replacement of the empirical model with a physiologically-based model as suggested recently8 may improve the accuracy of the estimation technique. Results of the present study should be applicable to prediction of infarct size with any model, since MB, unlike total CPK, is a more specific marker of myocardium and should facilitate improved prediction procedures, particularly in circumstances in which release of noncardiac CPK into the circulation is likely. 
